In breast cancer cells, TLR2 is overexpressed and can be activated by endogenous ligands such as HSPs, HMGB1 and other DAMPs, or by exogenous ligands derived from pathogens, like bacterial lipoproteins. This evidence concerns the gene HMGB1 and breast carcinoma.